TP53 and cancer: At the functional level the increase in p53 stability due to TG2 inhibition synergizes with the administration of a DNA-damaging anti-cancer drug such as doxorubicin inducing apoptosis in RCC cell lines and determining a reduced tumor volume in a xenograft model [28].